DLGAP2 and Alzheimer disease: Two‐way repeated‐measures ANOVA detected significant main effects of AD status (F[1, 63] = 8.36, p < 0.01), age (F[1, 63] = 29.3, p < 0.001), and an interaction between age × AD status (F[1, 63] = 14.85, p < 0.001); no significant main effect of DLGAP2 overexpression was detected.